Aclaris Therapeutics, Inc. (ACRS) Financials

ACRS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 197.4 million 40.2 million
2023-09-30 218.4 million 62.0 million
2023-06-30 235.6 million 55.9 million
2023-03-31 229.7 million 52.9 million

ACRS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -7.2 million 1.3 million
2023-09-30 -24.6 million 5.9 million
2023-06-30 -20.9 million 6.5 million
2023-03-31 -26.9 million 6.8 million

ACRS Net Income

No data available :(

ACRS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 119.1 million - 426000
2023-09-30 187.0 million - 310000
2023-06-30 210.8 million - 458000
2023-03-31 204.4 million - 603000

ACRS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 70.9 million
2023-09-30 70.8 million
2023-06-30 70.6 million
2023-03-31 66.9 million

ACRS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 441000 26.6 million 8.2 million 4.9 million
2023-09-30 84000 23.9 million 7.1 million -
2023-06-30 231000 25.3 million 8.3 million -
2023-03-31 553000 22.6 million 8.8 million -

ACRS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 17.6 million 6.4 million
2023-09-30 9.3 million 848000
2023-06-30 1.9 million 1.6 million
2023-03-31 2.5 million 1.9 million

ACRS

Price: $1.36

52 week price:
0.59
11.12

Earnings Per Share: -1.27 USD

P/E Ratio: -0.74

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 2.0 million

Ebitda: -18.6 million

Market Capitalization: 88.1 million

Links: